# reload+after+2024-01-20 03:46:08.597807
address1§10 Earlsfort Terrace
city§Dublin
zip§D02 T380
country§Ireland
phone§353 1 905 8020
website§https://www.muraloncology.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.
fullTimeEmployees§110
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Caroline J. Loew Ph.D.', 'age': 53, 'title': 'CEO & Director', 'yearBorn': 1970, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Adam D. Cutler B.A.', 'age': 49, 'title': 'CFO, Principal Financial Officer & Principal Accounting Officer', 'yearBorn': 1974, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Vicki L. Goodman M.D.', 'age': 53, 'title': 'Chief Medical Officer', 'yearBorn': 1970, 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge§86400
priceHint§2
payoutRatio§0.0
currency§USD
dateShortInterest§1702598400
exchange§NGM
quoteType§EQUITY
shortName§Mural Oncology plc
longName§Mural Oncology plc
firstTradeDateEpochUtc§1700836200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§56213005-23be-395c-8a2a-a8485dd4c587
gmtOffSetMilliseconds§-18000000
recommendationKey§none
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
